Skip to main content
padlock icon - secure page this page is secure

Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines

Buy Article:

$47.00 + tax (Refund Policy)

Abstract Background:

Pharmaceutical industry involvement in biomedicine has produced major benefits but has also caused concern. At present, there is no consensus as to how medical and government organizations should relate to the pharmaceutical industry and this is partly due to the absence of systematic study of the various alternatives. In Australia industry cooperation has been elicited through the ‘Quality Use of Medicines’ (QUM) framework within the ‘National Medicines Policy’. Little is known about the way employees of pharmaceutical companies respond to the QUM policy and strategies. Aims:

To examine the engagement of the Australian pharmaceutical industry with QUM with a view to assisting medical, government and consumer organizations who may wish to collaborate with industry. Methods:

We carried out a qualitative study using in-depth, semistructured interviews with industry employees, primarily from medical and regulatory affairs departments. Results:

Employees of pharmaceutical companies claim that collaboration is important, and that they are altruistic and committed to QUM. At the same time, there is little evidence from this study to support the notion that QUM has brought about structural changes to industry or is positioned as the central goal or framework in designing a company's operational strategies. Moreover, there is a significant degree of ambivalence towards governments and medical organizations. Conclusions:

Employees within the pharmaceutical industry claim a commitment to collaboration and QUM. While these claims cannot be taken entirely at face value, there is potential for meaningful collaboration with industry.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: health policy; pharmaceutical ethics; pharmaceutical industry; pharmacology; quality of healthcare

Document Type: Research Article

Affiliations: 1: Faculty of Medicine and 2: Centre for Values, Ethics and the Law in Medicine, Medical Foundation Building (K25), University of Sydney and Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia

Publication date: 01 April 2011

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more